CD38 Inhibitor 78c Attenuates Pro-Inflammatory Cytokine Expression and Osteoclastogenesis in Macrophages
William Lory, Nityananda Chowdhury, Bridgette Wellslager, Subramanya Pandruvada, Yan Huang, Özlem Yilmaz, Hong Yu, Alexander G Obukhov · 2024
Read CD38 Inhibitor 78c Attenuates Pro-Inflammatory Cytokine Expression and Osteoclastogenesis in Macrophages by William Lory, Nityananda Chowdhury, Bridgette Wellslager, Subramanya Pandruvada, Yan Huang, Özlem Yilmaz, Hong Yu, Alexander G Obukhov (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11640151.txt.
Description
William Lory and co-authors test an enzyme blocker against gum-driven inflammation in a 2024 study. CD38 is an enzyme that burns through NAD+, a molecule cells need for healthy work. Its levels rise during infection and inflammation, draining that supply.
The blocker 78c was fed to mouse macrophages in rising doses. It restored NAD+ levels and cut three flagship inflammatory signals. Two oral pathogens and aging-related compounds had provoked those signals. The drug also suppressed bone-eating cell formation driven by the RANKL signal. Blocking CD38 may calm both soft tissue and bone damage in gum disease.
Catalog record
| CREATOR | William Lory, Nityananda Chowdhury, Bridgette Wellslager, Subramanya Pandruvada, Yan Huang, Özlem Yilmaz, Hong Yu, Alexander G Obukhov |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |